We are live on ! Find out more
ECM

Everence Capital Management Portfolio holdings

AUM $1.9B
1-Year Est. Return 39.77%
This Fund
S&P 500
This Quarter Est. Return
-2.57%
1 Year Est. Return
+39.77%
3 Year Est. Return
+108.07%
5 Year Est. Return
+139.85%
10 Year Est. Return
+551.6%
AUM
$1.29B
AUM Growth
+$56.7M
Cap. Flow
+$35.2M
Cap. Flow %
2.74%
Top 10 Hldgs %
32.13%
Holding
815
New
91
Increased
169
Reduced
89
Closed
77

Top Buys

Rank Stock Value
1
HAS icon
Hasbro
HAS
+$4.61M
2
MSFT icon
Microsoft
MSFT
+$1.92M
3
MDT icon
Medtronic
MDT
+$1.84M
4
KO icon
Coca-Cola
KO
+$1.6M
5
META icon
Meta Platforms (Facebook)
META
+$1.38M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$11.3M
2
PEP icon
PepsiCo
PEP
+$4.03M
3
IBM icon
IBM
IBM
+$3.41M
4
COP icon
ConocoPhillips
COP
+$3.01M
5
TDG icon
TransDigm Group
TDG
+$1.84M

Sector Composition

Rank Sector Weight
1 Technology 23.23%
2 Miscellaneous 16.2%
3 Healthcare 10.83%
4 Financials 10.44%
5 Consumer Discretionary 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVS icon
76
CVS Health
CVS
$117B
$3.04M 0.24%
43,604
+11,570
+36% +$820K
QCOM icon
77
Qualcomm
QCOM
$203B
$3.04M 0.24%
27,400
REGN icon
78
Regeneron Pharmaceuticals
REGN
$80.5B
$3.02M 0.23%
3,671
ELV icon
79
Elevance Health
ELV
$90.2B
$2.96M 0.23%
6,800
+890
+15% +$404K
APD icon
80
Air Products & Chemicals
APD
$63.4B
$2.95M 0.23%
10,397
WM icon
81
Waste Management
WM
$84.8B
$2.94M 0.23%
19,254
+2,140
+13% +$346K
VRTX icon
82
Vertex Pharmaceuticals
VRTX
$130B
$2.9M 0.22%
8,324
BDX icon
83
Becton Dickinson
BDX
$50.2B
$2.86M 0.22%
11,060
+2,750
+33% +$743K
ISRG icon
84
Intuitive Surgical
ISRG
$135B
$2.84M 0.22%
9,710
+3,410
+54% +$1.06M
NKE icon
85
Nike
NKE
$53.1B
$2.81M 0.22%
29,440
CDNS icon
86
Cadence Design Systems
CDNS
$76.9B
$2.75M 0.21%
11,744
+1,120
+11% +$262K
GIS icon
87
General Mills
GIS
$19.6B
$2.74M 0.21%
42,780
+10,060
+31% +$711K
TJX icon
88
TJX Companies
TJX
$137B
$2.74M 0.21%
30,783
SYK icon
89
Stryker
SYK
$108B
$2.73M 0.21%
9,990
+1,190
+14% +$341K
PGR icon
90
Progressive
PGR
$125B
$2.69M 0.21%
19,310
-3,400
-15% -$447K
MRSH
91
Marsh
MRSH
$83.2B
$2.69M 0.21%
14,120
C icon
92
Citigroup
C
$224B
$2.6M 0.2%
63,306
DUK icon
93
Duke Energy
DUK
$92.1B
$2.59M 0.2%
29,394
+3,880
+15% +$356K
MS icon
94
Morgan Stanley
MS
$320B
$2.59M 0.2%
31,741
-3,650
-10% -$317K
ED icon
95
Consolidated Edison
ED
$39.4B
$2.56M 0.2%
29,931
-8,140
-21% -$741K
ROP icon
96
Roper Technologies
ROP
$37.1B
$2.56M 0.2%
5,280
+1,540
+41% +$755K
JCI icon
97
Johnson Controls International
JCI
$85.7B
$2.44M 0.19%
45,857
SBUX icon
98
Starbucks
SBUX
$111B
$2.38M 0.18%
26,022
ZTS icon
99
Zoetis
ZTS
$29.9B
$2.36M 0.18%
13,590
GWW icon
100
W.W. Grainger
GWW
$59.3B
$2.35M 0.18%
3,400

Similar funds

Everence Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Everence Capital Management held 815 positions worth $1.29B, up 4.6% from $1.23B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Everence Capital Management's Q3 2023 filing shows 91 new, 169 increased, 89 reduced and 77 closed positions. Its largest new stake was Dollar Tree: 6,940 shares worth $739K. The largest sale was UnitedHealth, an estimated $11.3M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Miscellaneous and Healthcare.

  • Everence Capital Management's largest Q3 2023 buy was Dollar Tree: 6,940 shares worth $739K.
  • Everence Capital Management added most to Hasbro in Q3 2023, an estimated $4.61M increase.
  • Everence Capital Management's biggest Q3 2023 reduction was PepsiCo, cutting an estimated $4.03M.
  • Everence Capital Management fully exited UnitedHealth in Q3 2023, selling an estimated $11.3M.
  • Everence Capital Management's ten largest holdings make up 32% of its $1.29B portfolio in Q3 2023.
  • Everence Capital Management opened 91 new positions and closed 77 in Q3 2023.
  • Everence Capital Management's portfolio value rose 4.6% quarter-over-quarter to $1.29B.

Based on Everence Capital Management's 13F filing for Q3 2023, filed 16 Oct 2023.